4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-059886
Chief Executive Officer sold 10,916 shares at an average $29.35 ($320,373)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ceesay Abraham Chief Executive Officer | 2026-02-18 | Sale 10b5-1 | −3,552 | $29.05 | $103,191 | 558,528 | D |
| Ceesay Abraham Chief Executive Officer | 2026-02-18 | Sale 10b5-1 | −2,281 | $29.80 | $67,970 | 556,247 | D |
| Ceesay Abraham Chief Executive Officer | 2026-02-18 | Sale 10b5-1 | −2,983 | $29.04 | $86,639 | 22,829 | I |
| Ceesay Abraham Chief Executive Officer | 2026-02-18 | Sale 10b5-1 | −2,100 | $29.80 | $62,573 | 20,729 | I |
| Open-market sales · 10,916 sh · avg $29.35 · $320,373 | |||||||
Loading xslF345X05/ownership.xml…